MedPath
HSA Approval

Zynor Tablet 5mg

SIN14213P

Zynor Tablet 5mg

Zynor Tablet 5mg

August 22, 2012

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C08CA01

amlodipine

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

Xepa-Soul Pattinson (Malaysia) Sdn Bhd

Active Ingredients

Amlodipine Besylate 6.93mg eqv to Amlodipine

5mg

Amlodipine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Zynor Tablet 5mg - HSA Approval | MedPath